Article info

Download PDFPDF
A PDGFRA promoter polymorphism, which disrupts the binding of ZNF148, is associated with primitive neuroectodermal tumours and ependymomas
  1. Correspondence to:
 Gijs Afink
 Department of Oncology-Pathology, Karolinska Institutet, CCK R8:05 KS, 17176 Stockholm, Sweden;gijs.afinkcck.ki.se
View Full Text

Citation

De Bustos C, Smits A, Strömberg B, et al
A PDGFRA promoter polymorphism, which disrupts the binding of ZNF148, is associated with primitive neuroectodermal tumours and ependymomas

Publication history

  • Received June 22, 2004
  • Accepted August 6, 2004
  • First published January 5, 2005.
Online issue publication 
April 27, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.